SCHEMBL1930780

SCHEMBL1930780

CC[C@@](C)(Cc1ccc(Cl)c(N)c1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 14/20 0.48
PPARD Q03181 6/20 0.48
PPARG P37231 5/20 0.48
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HPGD P15428 4/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
POLB P06746 2/20 0.40
CYP3A4 P08684 2/20 0.40
MAPT P10636 2/20 0.40
ALOX15 P16050 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
EGFR P00533 1/20 0.40
FYN P06241 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1932111 1.00 PPARA (0.48) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1932453 1.00 PPARA (0.48) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1932072 0.86 NPC1 (0.40) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1931036 0.84 PPARA (0.43) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1904138 0.83 NPC1 (0.39) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1932879 0.83 NPC1 (0.44) PPARANPC1RAB9AHPGDKDM4E
SCHEMBL1930976 0.82 PPARA (0.42) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1931793 0.82 PPARA (0.42) PPARAPPARDPPARGNPC1RAB9A
SCHEMBL1930917 0.82 PPARA (0.48) PPARAPPARDPPARGHPGDKDM4E
SCHEMBL11527067 0.78 PPARA (0.54) PPARAPPARDPPARGCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9018414-B2 Substituted 3-phenylpropionic acids and the use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-28 US disclosed
US-20140142069-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-05-22 US disclosed
US-20110130445-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142069-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF FABP3, PC, PAH PPARA 5/4885PPARD 36/4885PPARG 15/4885
US-20110130445-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF FABP3, PC, PAH PPARA 5/4885PPARD 36/4885PPARG 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.